MedTrace Logo

Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1

NCT00040040 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2017-01-11

No results posted yet for this study

Summary

The purpose of this study is to assess potential interactions between intravenous (IV) methamphetamine and oral bupropion.

Conditions

  • Amphetamine-Related Disorders

Interventions

DRUG

Bupropion

Sponsors & Collaborators

Principal Investigators

  • Thomas Newton, M.D. · National Institute on Drug Abuse (NIDA)

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-06-30
Completion
2003-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00040040 on ClinicalTrials.gov